<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Milovancev, Milan</style></author><author><style face="normal" font="default" size="100%">Muir, Peter</style></author><author><style face="normal" font="default" size="100%">Manley, Paul A</style></author><author><style face="normal" font="default" size="100%">Seeherman, Howard J</style></author><author><style face="normal" font="default" size="100%">Schaefer, Susan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical application of recombinant human bone morphogenetic protein-2 in 4 dogs.</style></title><secondary-title><style face="normal" font="default" size="100%">Veterinary surgery : VS</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Vet Surg</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animals</style></keyword><keyword><style  face="normal" font="default" size="100%">Biocompatible Materials</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone Cements</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone Morphogenetic Protein 2</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone Morphogenetic Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone Plates</style></keyword><keyword><style  face="normal" font="default" size="100%">Collagen</style></keyword><keyword><style  face="normal" font="default" size="100%">Dogs</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Femoral Fractures</style></keyword><keyword><style  face="normal" font="default" size="100%">Fracture Healing</style></keyword><keyword><style  face="normal" font="default" size="100%">Fractures, Bone</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Humeral Fractures</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Osteotomy</style></keyword><keyword><style  face="normal" font="default" size="100%">Recombinant Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style  face="normal" font="default" size="100%">Tendon Injuries</style></keyword><keyword><style  face="normal" font="default" size="100%">Transforming Growth Factor beta</style></keyword><keyword><style  face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007 Feb</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">36</style></volume><pages><style face="normal" font="default" size="100%">132-40</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">To describe outcome in dogs with insufficient bone healing treated with recombinant human bone morphogenetic protein-2 (rhBMP-2).</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/17335420?dopt=Abstract</style></custom1></record></records></xml>